S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q1 2024

BVF Partners

Period: Q1 2024 Β· Filed: 2024-05-15
View on SEC EDGAR β†—
AUM
$3.64B
Total portfolio value
Positions
62
Reported securities
Top Holding
MLTX
30.0% $1.09B
QoQ Changes
+3 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$1.09B30.04%$48.60$18.95-61.0%
30.0%
KYMRKYMERA THERAPEUTICS INC$207.5M5.70%$39.42$113.51+187.9%
5.7%
RVMDREVOLUTION MEDICINES INC$192.8M5.30%$31.68$189.24+497.4%
5.3%
FDMT4D MOLECULAR THERAPEUTICS IN$125.0M3.44%$30.01$13.00-56.7%
3.4%
GHRSGH RESEARCH PLC$110.9M3.05%$11.08$27.01+143.8%
3.0%
JANXJANUX THERAPEUTICS INC$109.9M3.02%$37.69$15.54-58.8%
3.0%
MIRMMIRUM PHARMACEUTICALS INC$109.8M3.02%$25.45$125.59+393.5%
3.0%
PTGXPROTAGONIST THERAPEUTICS INC$108.7M2.99%$28.28$131.62+365.4%
3.0%
IONSIONIS PHARMACEUTICALS INC$105.3M2.89%$43.94$81.80+86.2%
2.9%
OLMAOLEMA PHARMACEUTICALS INC$103.4M2.84%$10.89$12.64+16.1%
2.8%
KURAKURA ONCOLOGY INC$102.1M2.81%$21.82$11.10-49.1%
2.8%
XOMAXOMA CORP DEL$87.4M2.40%$25.25$43.00+70.3%
2.4%
CGONCG ONCOLOGY INC$82.7M2.27%$42.76$70.36+64.5%
2.3%
TYRATYRA BIOSCIENCES INC$76.4M2.10%$16.88$30.62+81.4%
2.1%
EPIXESSA PHARMA INC$74.3M2.04%β€”β€”
2.0%
ZYMEZYMEWORKS INC$61.8M1.70%$9.88$26.31+166.3%
1.7%
LKFTGALAPAGOS NV$60.0M1.65%$32.48$30.39-6.4%
1.6%
CGEMCULLINAN ONCOLOGY INC$54.5M1.50%$17.65$17.63-0.1%
1.5%
MRUSMERUS N V$52.8M1.45%β€”β€”
1.4%
IDYAIDEAYA BIOSCIENCES INC$51.0M1.40%$42.52$37.65-11.4%
1.4%
ANNXANNEXON INC$50.2M1.38%$6.63$5.46-17.6%
1.4%
RPTXREPARE THERAPEUTICS INC$48.7M1.34%β€”β€”
1.3%
ETNB89BIO INC$47.1M1.30%β€”β€”
1.3%
SNDXSYNDAX PHARMACEUTICALS INC$44.6M1.23%$23.78$21.82-8.2%
1.2%
ACIUAC IMMUNE SA$43.1M1.19%$2.73$2.51-8.1%
1.2%
THRDTHIRD HARMONIC BIO INC$41.2M1.13%β€”β€”
1.1%
ENGNENGENE HOLDINGS INC$38.2M1.05%$16.89$1.78-89.5%
1.1%
NAMSNEWAMSTERDAM PHARMA COMPANY$36.0M0.99%$21.37$34.83+63.0%
1.0%
GPCRSTRUCTURE THERAPEUTICS INC$34.8M0.96%$40.90$53.45+30.7%
1.0%
ROIVROIVANT SCIENCES LTD$28.9M0.79%$10.43$35.13+236.8%
0.8%

Quarter-on-Quarter Activity

Q1 2024 vs. Q4 2023

New Positions (3)

TickerIssuerNotionalSince Filing
CGONCG ONCOLOGY INC$82.7M+64.5%
IMUXIMMUNIC INC$11.8M
SABSSAB BIOTHERAPEUTICS INC$4.2M

Exited Positions (8)

TickerIssuerNotional
AXSMAXSOME THERAPEUTICS INC$157.7M
CNTACENTESSA PHARMACEUTICALS PLC$69.8M
RLAYRELAY THERAPEUTICS INC$43.7M
XENEXENON PHARMACEUTICALS INC$41.0M
SLNSILENCE THERAPEUTICS PLC$26.2M
SYRESPYRE THERAPEUTICS INC$14.8M
STROSUTRO BIOPHARMA INC$14.4M
ITOSITEOS THERAPEUTICS INC$13.8M

Increased (4)

TickerIssuerNotionalShares Ξ”Since Filing
ALLKALLAKOS INC$-2.5M+93.5%
UNCYUNICYCIVE THERAPEUTICS INC$3.1M+70.5%
TYRATYRA BIOSCIENCES INC$38.5M+70.1%+81.4%
DCTHDELCATH SYS INC$1.7M+23.1%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
LXRXLEXICON PHARMACEUTICALS INC$-33.3M-93.1%
CRVSCORVUS PHARMACEUTICALS INC$-1.8M-73.6%
MRUSMERUS N V$-22.9M-57.4%
OVIDOVID THERAPEUTICS INC$-10.3M-43.7%
JANXJANUX THERAPEUTICS INC$60.8M-36.2%-58.8%
KURAKURA ONCOLOGY INC$-3.9M-35.1%-49.1%
PTGXPROTAGONIST THERAPEUTICS INC$-23.1M-34.6%+365.4%
IDYAIDEAYA BIOSCIENCES INC$-10.5M-32.8%-11.4%
← Back to Hedge Funds